Astrazeneca Pharma India informs about updates

20 Jan 2024 Evaluate
Astrazeneca Pharma India has informed that AstraZeneca Pharma India has received permission to Import pharmaceutical formulations of new drug for sale or for distribution in Form CT-20 from Central Drugs Standard Control Organisation for Andexanet alfa powder for solution for infusion 200mg (Andexxa).

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

8397.90 -97.80 (-1.15%)
19-Mar-2026 12:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1762.75
Dr. Reddys Lab 1271.85
Cipla 1247.60
Zydus Lifesciences 884.60
Lupin 2267.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×